MedPath

KLOR-Con/EF

KLOR-CON/EF Potassium Bicarbonate Effervescent Tablets for Oral Solution, USP

Approved
Approval ID

f9d85c4f-aa46-40b2-ad76-89dbf6ec8e4d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 30, 2020

Manufacturers
FDA

Upsher-Smith Laboratories, Inc.

DUNS: 079111820

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Potassium Bicarbonate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0245-5326
Product Classification
G
Generic Name
Potassium Bicarbonate
Product Specifications
Route of AdministrationORAL
Effective DateJune 30, 2020
FDA Product Classification

INGREDIENTS (6)

Potassium BicarbonateActive
Quantity: 978 mg in 1 1
Code: HM5Z15LEBN
Classification: ACTIM
FD&C Yellow No. 6Inactive
Code: H77VEI93A8
Classification: IACT
TalcInactive
Code: 7SEV7J4R1U
Classification: IACT
Mineral OilInactive
Code: T5L8T28FGP
Classification: IACT
SaccharinInactive
Code: FST467XS7D
Classification: IACT
Microcrystalline CelluloseInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KLOR-Con/EF - FDA Drug Approval Details